An individual who has kidney cancer and who is unable to undergo a surgical procedure to remove their malignancy may need to have cryoablation as part of their treatment. Numerous health ...

kidney, lung and liver. Per IceCure Medical, the FDA approval for the XSense Cryoablation System marks a significant step in the medical technology landscape. Following the FDA clearance ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

Thermoablative procedures such as radiofrequency ablation and cryoablation ... such as a single kidney or chronic kidney disease, but since then the organ-preserving approach has increasingly ...

Kidney cancer is a largely unmet need ... FDA Granted Regulatory Clearance for XSense™ Cryoablation System with CryoProbes: The next-generation XSense™ system is cleared for the same ...

External beam radiation therapy and cryoablation can both be used to treat localized prostate cancer. Quality of life outcomes are similar with the two forms of treatment, with the exception of ...

IceCure Medical (ICCM) has submitted a regulatory filing with China’s National Medical Products Administration for the approval of its ProSense ...

The ProSense® Cryoablation System is a minimally invasive ... destruction in benign and cancerous lesions, including breast, kidney, lung, and liver. ProSense® enhances patient and provider ...